DEVELOPMENT OF AN ANTIIDIOTYPE MONOCLONAL-ANTIBODY MIMICKING THE STRUCTURE OF LIPOPOLYSACCHARIDE (LPS) INNER-CORE DETERMINANTS

被引:6
作者
FIELD, S
POLLACK, M
MORRISON, DC
机构
[1] UNIFORMED SERV UNIV HLTH SCI,F EDWARD HEBERT SCH MED,DEPT MED,BETHESDA,MD 20814
[2] UNIV KANSAS,MED CTR,CTR CANC,KANSAS CITY,KS 66160
关键词
LIPOPOLYSACCHARIDE (LPS); ANTIIDIOTYPE MONOCLONAL ANTIBODY; LPS INNER-CORE; ANTI-LPS ANTIBODIES;
D O I
10.1006/mpat.1993.1061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An anti-idiotype antibody has been developed which is specific for idiotypic determinants of a BALB/c mouse IgG3 monoclonal antibody (MAbY1-4A6) directed against the inner-core Kdo region of lipopolysaccharide (LPS). Armenian hamsters were immunized with MAbY1-4A6 and splenocytes from immunized animals fused with Sp2/0 myeloma cells. Eight clones secreting antibodies that bound to MAbY1-4A6, but not control IgG3, were identified and subcloned. Culture supernatants from one hybridoma, termed MAb4G2, contain monoclonal antibody that binds to the variable region of MAbY1-4A6 and dose-dependently inhibits binding of MAbY1-4A6 to Re chemotype rough mutant LPS (Re-LPS). This antibody also inhibits binding of three additional mouse monoclonal antibodies specific for the inner-core of Re-LPS. MAb4G2 also recognizes a significant proportion of antibodies present in polyclonal R-chemotype antisera generated in mice (Re-LPS) and rabbits (J5 Rc-LPS). Mice and hamsters immunized with MAb4G2 or Re-LPS generate antibodies which cross-react with both immunogens. Cumulatively, these data suggest that MAb4G2 can function as an internal image of the Kdo-specific monoclonal antibody, MAbY1-4A6, mimicking the antigenic structure and immunogenicity of a portion of the LPS inner-core Kdo region. © 1993 Academic Press.
引用
收藏
页码:103 / 120
页数:18
相关论文
共 42 条
[1]  
BAUMGARTNER JD, 1985, LANCET, V2, P59
[2]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[3]  
BRAUDE, 1966, MOL BIOL GRAM NEGATI, V133
[4]   ANTIBODY TO CELL-WALL GLYCOLIPID OF GRAM-NEGATIVE BACTERIA - INDUCTION OF IMMUNITY TO BACTEREMIA AND ENDOTOXEMIA [J].
BRAUDE, AI ;
ZIEGLER, EJ ;
DOUGLAS, H ;
MCCUTCHAN, JA .
JOURNAL OF INFECTIOUS DISEASES, 1977, 136 :S167-S173
[5]  
BRAUDE AI, 1972, J IMMUNOL, V108, P505
[6]   NEUTRALIZATION OF MENINGOCOCCAL ENDOTOXIN BY ANTIBODY TO CORE GLYCOLIPID [J].
DAVIS, CE ;
ZIEGLER, EJ ;
ARNOLD, KF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 147 (04) :1007-1017
[7]   ANTI-IDIOTYPIC ANTIBODIES - IMPLICATIONS OF INTERNAL IMAGE BASED VACCINES FOR INFECTIOUS-DISEASES [J].
DREESMAN, GR ;
KENNEDY, RC .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (05) :761-765
[8]   A NEW METHOD FOR EXTRACTION OF R-LIPOPOLYSACCHARIDES [J].
GALANOS, C ;
LUDERITZ, O ;
WESTPHAL, O .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1969, 9 (02) :245-&
[9]   A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS [J].
GREENMAN, RL ;
SCHEIN, RMH ;
MARTIN, MA ;
WENZEL, RP ;
MACINTYRE, NR ;
EMMANUEL, G ;
CHMEL, H ;
KOHLER, RB ;
MCCARTHY, M ;
PLOUFFE, J ;
RUSSELL, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (08) :1097-1102
[10]  
JACOBS DM, 1975, J IMMUNOL, V114, P360